- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00776048
Validation of an Obstacle Course Used in Patients With Muscle Tightness
June 23, 2010 updated by: Kessler Foundation
The Validation of a New Method to Evaluate the Effects of Chemoneurolytic Intervention on Balance and Community Ambulation in Spastic Hemiplegic Patients
This study is being conducted to compare healthy patients versus patients with muscle tightness in their leg(s) after an acquired brain injury using walking trials time, a balance test, and foot pressure data.
This data is obtained using foot pressure sensors, timers, and distance walked.
Study Overview
Status
Unknown
Detailed Description
This study is being conducted to demonstrate the objective utility of the use of pedobarography as a tool to differentiate normal controls from people with spastic gait as well as having utility in objectification of treatment effect on level surfaces and on a ADA based obstacle course.
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
West Orange, New Jersey, United States, 07052
- KesslerMRREC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects ages > 18 years of age for this study.
A total of up to 10 age matched controls and 30 clinical patients with lower extremity spasticity will be enrolled.
Of the 30 clinical patients, 20 clinical patients will have received BOTOX ® injections from their clinical physician after their first visit.
Description
Inclusion Criteria:
- Patients > 18 years of age
- Must wear shoe size 5½ - 11 US womens or size 6 - 13 US mens
- For treatment group be a clinical patient being treated for lower extremity spasticity
Exclusion Criteria:
- Age matched controls must have no significant neurological or orthopedic disease that would effect their gait
- Clinical patients who are unable to walk for 1 minute
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
ABI
Acquired brain injury with lower limb spasticity
|
|
Healthy Controls
Age matched healthy controls
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To demonstrate the objective utility of the use of pedobarography to differentiate normal controls from people with spastic gait as well as having utility in objectification of treatment effect on level surfaces and on a ADA based obstacle course.
Time Frame: 4 months post acquired brain injury
|
4 months post acquired brain injury
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elie P Elovic, M.D., Kessler Foundation
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Anticipated)
December 1, 2009
Study Completion (Anticipated)
December 1, 2009
Study Registration Dates
First Submitted
October 16, 2008
First Submitted That Met QC Criteria
October 17, 2008
First Posted (Estimate)
October 20, 2008
Study Record Updates
Last Update Posted (Estimate)
June 24, 2010
Last Update Submitted That Met QC Criteria
June 23, 2010
Last Verified
October 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Wounds and Injuries
- Craniocerebral Trauma
- Trauma, Nervous System
- Multiple Sclerosis
- Brain Injuries
- Brain Injuries, Traumatic
Other Study ID Numbers
- E56806
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.